Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 1048 entries
View as:

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT05172999 Org: User:
Start: 01/08/22 End: 06/30/26 Due: 06/30/27

Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP

Phase: N/A Priority: Normal
NCT ID: NCT05454358 Org: User:
Start: 08/02/22 End: 07/09/30 Due: 07/09/31

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04581876 Org: User:
Start: 11/01/19 End: 03/01/23 Due: 03/01/24

Active Surveillance for Limited GGNs

Phase: N/A Priority: Normal
NCT ID: NCT06394037 Org: User:
Start: 05/01/25 End: 05/01/38 Due: 05/01/39

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06795503 Org: User:
Start: 02/28/25 End: 07/31/31 Due: 07/31/32

The Effect of Modified Valsalva Maneuver on Filling Degree of Internal Jugular Vein

Phase: N/A Priority: Normal
NCT ID: NCT02095002 Org: User:
Start: 01/31/14 End: - Due: -

Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04192903 Org: User:
Start: 12/25/19 End: 06/01/22 Due: 06/01/23

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Phase: N/A Priority: Normal
NCT ID: NCT02965248 Org: User:
Start: 11/30/16 End: 11/30/23 Due: 11/30/24

Treatment After Palbociclib-containing Regimens

Phase: N/A Priority: Normal
NCT ID: NCT04517318 Org: User:
Start: 08/15/17 End: 07/15/21 Due: 07/15/22

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05939063 Org: User:
Start: 10/01/23 End: 08/31/28 Due: 08/31/29

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02037997 Org: User:
Start: 12/31/13 End: 12/31/17 Due: 12/31/18

Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology

Phase: N/A Priority: Normal
NCT ID: NCT06366581 Org: User:
Start: 03/01/23 End: 03/01/24 Due: 03/01/25

Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05633641 Org: User:
Start: 10/19/22 End: 12/31/24 Due: 12/31/25

Cola Ingestion for Esophageal Bolus Impaction

Phase: N/A Priority: Normal
NCT ID: NCT06652620 Org: User:
Start: 10/01/24 End: 06/30/26 Due: 06/30/27

Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02

Phase: N/A Priority: Normal
NCT ID: NCT05205200 Org: User:
Start: 06/06/22 End: 08/01/26 Due: 08/01/27

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06943235 Org: User:
Start: 04/30/25 End: 12/30/27 Due: 12/30/28

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Phase: N/A Priority: Normal
NCT ID: NCT05953168 Org: User:
Start: 08/31/23 End: 08/31/26 Due: 08/31/27

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06649331 Org: User:
Start: 10/21/24 End: 09/30/27 Due: 09/30/28

Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04136535 Org: User:
Start: 10/18/19 End: 12/31/21 Due: 12/31/22

Breast Cancer PET/CT Imaging With 68Ga-pAKTi

Phase: N/A Priority: Normal
NCT ID: NCT06943313 Org: User:
Start: 04/21/25 End: 12/31/26 Due: 12/31/27

Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT04980599 Org: User:
Start: 01/10/21 End: 12/31/21 Due: 12/31/22

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Phase: N/A Priority: Normal
NCT ID: NCT02742675 Org: User:
Start: 09/30/15 End: 03/31/23 Due: 03/31/24

Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05303038 Org: User:
Start: 05/01/22 End: 04/01/24 Due: 04/01/25

Study of Apatinib as an Inhibitor of Tumor Angiogenesis

Phase: N/A Priority: Normal
NCT ID: NCT00633490 Org: User:
Start: 07/31/07 End: 06/30/08 Due: 06/30/09

Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04066322 Org: User:
Start: 08/25/19 End: 07/25/25 Due: 07/25/26